Baylor Institute of Metabolic Diseases Site Number : 840001 — Dallas, Texas

Baylor Institute of Metabolic Diseases Site Number : 840001 is a clinical research site located in Dallas, Texas, United States 75226.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Baylor Institute of Metabolic Diseases Site Number : 840001 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Gaucher Disease Type 1, Gaucher Disease Type 3.

Sponsors: Genzyme, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Baylor Institute of Metabolic Diseases Site Number : 840001?

Baylor Institute of Metabolic Diseases Site Number : 840001 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Baylor Institute of Metabolic Diseases Site Number : 840001 conducted?

Baylor Institute of Metabolic Diseases Site Number : 840001 has 1 clinical trials on record, with 1 currently active. Their work covers Gaucher Disease Type 1, Gaucher Disease Type 3.

Is Baylor Institute of Metabolic Diseases Site Number : 840001 accredited by Crixeo Clinical Trials?

Baylor Institute of Metabolic Diseases Site Number : 840001 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Baylor Institute of Metabolic Diseases Site Number : 840001?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.